Growth Metrics

Soleno Therapeutics (SLNO) EBIT (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Soleno Therapeutics 2.76 Bn 2.51 Bn 93.41 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -20.97%
Dec 31, 2025 79.04%
Sep 30, 2025 438.77%
Jun 30, 2025 85.74%
Mar 31, 2025 22.62%
Dec 31, 2024 26.30%
Sep 30, 2024 -222.55%
Jun 30, 2024 -5.93%
Mar 31, 2024 -68.76%
Dec 31, 2023 -33.98%
Sep 30, 2023 -20.40%
Jun 30, 2023 -1.82%
Mar 31, 2023 -50.96%
Dec 31, 2022 10.02%
Sep 30, 2022 8.02%
Jun 30, 2022 -17.43%
Mar 31, 2022 -92.37%
Dec 31, 2021 63.78%
Sep 30, 2021 25.25%
Jun 30, 2021 -21.07%
Mar 31, 2021 -15.07%
Dec 31, 2020 -1.27%
Sep 30, 2020 29.80%
Jun 30, 2020 -20.59%
Mar 31, 2020 -37.47%
Dec 31, 2019 -10.09%
Sep 30, 2019 -9.07%
Jun 30, 2019 -12.96%
Mar 31, 2019 -40.82%
Dec 31, 2018 8.84%
Sep 30, 2018 -13.62%
Jun 30, 2018 1.78%
Mar 31, 2018 33.16%
Dec 31, 2017 -97.61%
Sep 30, 2017 11.35%
Jun 30, 2017 -116.17%
Mar 31, 2017 25.10%
Dec 31, 2016 6.85%
Sep 30, 2016 14.25%
Jun 30, 2016 46.16%
Mar 31, 2016 -21.57%
Dec 31, 2015 -10.17%
Sep 30, 2015 -4.57%
Jun 30, 2015 -25.47%
Mar 31, 2015 -31.44%
Dec 31, 2014 -39.51%
Sep 30, 2014 -1.22%
Jun 30, 2014 -91.08%
Mar 31, 2014 -22.19%
Dec 31, 2013 43.63%